Location: Webinar

Agenda:

• NMPA medical device regulations/guidelines and major updates
• NMPA medical device QMS/GMP and its alignment with international regulations or standards
• Medical device product lifecycle management with a focus on design control
• Responsibilities and potential risks of medical device licence holders in post-market surveillance
• How to choose distributors who are compliant with NMPA requirements in China
• Adverse event reporting management under Order 739
• Recall/field action management under Order 739
• Draft and submit a Periodic Risk Evaluation Report to China’s NMPA

Organiser: Inspirative Medical

Contact: info@inspirativemed.com